Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep:105:106847.
doi: 10.1016/j.ijsu.2022.106847. Epub 2022 Aug 19.

Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects

Affiliations

Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects

Sandip Chakraborty et al. Int J Surg. 2022 Sep.
No abstract available

PubMed Disclaimer

References

    1. Reynolds M.G., McCollum A.M., Nguete B., Lushima R.S., Petersen B.W. Improving the care and treatment of monkeypox patients in low-resource settings: applying evidence from contemporary biomedical and smallpox biodefense research. Viruses. 2017;9(12):380. doi: 10.3390/v9120380. - DOI - PMC - PubMed
    1. Rizk J.G., Lippi G., Henry B.M., Forthal D.N., Rizk Y. Prevention and treatment of monkeypox. Drugs. 2022;82(9):957–963. doi: 10.1007/s40265-022-01742-y. - DOI - PMC - PubMed
    1. Diaz J.H. The disease ecology, epidemiology, clinical manifestations, management, prevention, and Control of increasing human infections with animal orthopoxviruses. Wilderness Environ. Med. 2021;32(4):528–536. doi: 10.1016/j.wem.2021.08.003. - DOI - PMC - PubMed
    1. Rodríguez-Cuadrado F.J., Pinto-Pulido E.L., Fernández-Parrado M. RF-potential treatments for monkeypox. Actas Dermosifiliogr. 2022 doi: 10.1016/j.ad.2022.06.013. - DOI - PMC - PubMed
    1. Merchlinsky M., Albright A., Olson V., Schiltz H., Merkeley T., Hughes C., Petersen B., Challberg M. The development and approval of tecoviromat (TPOXX®), the first antiviral against smallpox. Antivir. Res. 2019;168:168–174. doi: 10.1016/j.antiviral.2019.06.005. - DOI - PMC - PubMed

Substances